MATERNAL and CHILD SURVIVAL PROGRAM NIGERIA – ROUTINE IMMUNIZATION Quarterly Report Program Year 3 Second Quarter January 1St 2017 to March 31St 2017
Total Page:16
File Type:pdf, Size:1020Kb
MATERNAL AND CHILD SURVIVAL PROGRAM NIGERIA – ROUTINE IMMUNIZATION Quarterly Report Program Year 3 Second Quarter January 1st 2017 to March 31st 2017 Agreement Number: AID-OAA-A-14-00028 Activity Start Date and End Date: September 1, 2014 – December 31, 2018 Activity Manager: Dr. Yakubu Joel Cherima Submitted by: Dr. Femi Oyewole, National Immunization Technical Advisor John Snow, Inc. (JSI) Plot 448 Reuben Okoya Street Wuye, Abuja, Nigeria PROGRAM SUMMARY Maternal and Child Survival Program Nigeria - Program Name: Routine Immunization Activity Start Date and End Date: September 1, 2014 – December 31, 2018 Name of Prime Implementing John Snow, Inc. (JSI) Partner: Agreement Number: AID-OAA-A-14-00028 National Primary Health Care Development Agency (NPHCDA), Expanded Programme on Immunization (EPI), The Bill & Melinda Gates Foundation, Dangote Foundation, Solina Health, World Health Organization (WHO), United Nations Children’s Fund (UNICEF), US Centers for Disease Control and Prevention N-STOP Project (CDC-NSTOP), European Union-funded Support Immunization Governance Major Counterpart Organizations: in Nigeria (EU-SIGN), Bauchi and Sokoto State Primary Health Care Development Agencies (BSPHCDA and SSPHCDA, respectively), Ministries of Local Government (MoLGs), Local Government Authorities (LGAs), Northern Traditional and Religious Leaders’ Council, Ward Development Committees (WDCs), Community-Based Health Volunteers (CBHVs), Chigari Foundation Geographic Coverage (cities and or Abuja FCT, Bauchi and Sokoto states, Nigeria countries): st st Reporting Period: Program Year 3, January 1 2017 to March 31 2017 ACRONYMS AND ABBREVIATIONS bOPV Bivalent Oral Polio Vaccine BMGF The Bill and Melinda Gates Foundation BSPHCDA Bauchi State Primary Health Care Development Agency CBHV Community Based Health Volunteer CCE Cold Chain Equipment CDC N-STOP U.S. Centers for Disease Control and Prevention N-STOP Project cMYP Comprehensive EPI Multi Year Plan CRGs Community Resource Groups DF Dangote Foundation DHIS-2 District Health Information System version 2 DVD-MT District Vaccine Device-Management Tool DQS Data Quality Self-Assessment EOC Emergency Operations Center EU-SIGN European Union-funded Support Immunization Governance in Nigeria Health Facility Health Facility HMIS Health Management Information System HW Health Worker IPD Immunization Plus Day IPV Inactivated Polio Vaccine LGA Local Government Area LIO LGA Immunization Officer M&E Monitoring and Evaluation MCSP Maternal and Child Survival Program MMR Measles, Mumps, and Rubella MOU Memorandum of Understanding NITA National Immunization Technical Advisor NPHCDA National Primary Health Care Development Agency NVI New Vaccine Introduction OPV Oral Polio Vaccine PCV Pneumococcal Conjugate Vaccine PHC Primary Health Care PHCUOR Primary Health Care Under One Roof PPM Planned Preventive Maintenance PY Program Year REW Reaching Every Ward RI Routine Immunization SDD Solar Direct Drive SITA State Immunization Technical Advisor SITO State Immunization Technical Officer SLWG State Logistics Working Group SPHCDA State Primary Health Care Development Agency SSPHCDA Sokoto State Primary Health Care Development Agency STTA Short-Term Technical Assistance TFI Task Force on Immunization tOPV Trivalent Oral Polio Vaccine TSHIP Targeted States Health Impact Project TP Technical Partner UNICEF United Nations Children’s Fund USAID United States Agency for International Development VDC Village Development Committee VVM Vaccine Vial Monitor WHO World Health Organization 1 | Page TABLE OF CONTENTS ACRONYMS AND ABBREVIATIONS .......................................................................................... 1 1. PROGRAM OVERVIEW ............................................................................................................ 3 1.1 Quarterly Achievement Highlights ....................................................................................... 4 2. ACTIVITY IMPLEMENTATION PROGRESS ........................................................................ 8 2.1 2.1 Progress Summary ............................................................................................................. 8 2.2 MOU Thematic Area 1: Governance and Accountability ............................................. 11 2.3 MOU Thematic Area 2: Improving Accessibility and Utilization ................................. 14 2.4 MOU Thematic Area 3: Vaccine Security, Cold Chain, and Logistics ........................ 15 2.5 MOU Thematic Area 4: Monitoring and Evaluation/Supportive Supervision............ 16 2.6 MOU Thematic Area 5: Community Partnership ........................................................... 17 2.7 MOU Thematic Area 6: Capacity Building and Training ................................................ 20 2.8 National Level Support .......................................................................................................... 21 3. Cross Cutting Activities ........................................................................................................... 22 4. Learning activities: ...................................................................................................................... 23 5. Implementation Challenges ...................................................................................................... 25 6. Management and Administration ............................................................................................ 25 7. Sub-Agreements ......................................................................................................................... 26 8. Activities Planned Next Quarter ............................................................................................ 26 2 | Page 1. PROGRAM OVERVIEW The Maternal and Child Survival Program (MSCP) is a global U.S. Agency for International Development (USAID) cooperative agreement to introduce and support high-impact health interventions in 24 priority countries, including Nigeria, with the ultimate goal of ending preventable maternal and child deaths (EPCMD) within a generation. MCSP engages governments, policymakers, private sector leaders, health care providers, civil society, faith-based organizations, and communities in adopting and accelerating proven approaches to address the major causes of maternal, newborn, and child mortality such as postpartum hemorrhage (PPH), birth asphyxia, and diarrhea, respectively, and to improve the quality of health services from the household to the hospital. The program will tackle these issues through approaches that focus on health systems strengthening, household, and community mobilization, gender integration, and eHealth, among others. MCSP has launched multiple activities in Nigeria. These include a routine immunization (RI) technical assistance program in Bauchi and Sokoto states, a project aimed at reducing maternal, newborn, and child maternal deaths in Kogi and Ebonyi states (MNCH) and a public-private partnership through the Mobile Alliance for Maternal Action (MAMA). This quarterly report covers MCSP/Nigeria RI program assistance to Bauchi and Sokoto States. The program aims to strengthen the RI system to increase and sustain RI coverage and reduce childhood illness and death. USAID MCSP’s RI program is fully operational at the national level (in Abuja), and in Bauchi and Sokoto states. MCSP/Nigeria RI’s program objectives are as follows: • Objective 1: Support State-led and State-owned efforts to achieve >80% RI coverage in every ward of Bauchi State by the end of December 2017, and in Sokoto State by the end of December 2018. • Objective 2: Support State-led and State-owned efforts to expand the availability and quality of RI services by providing technical assistance in the areas of capacity building and training, supportive supervision, monitoring and use of data, supply/cold chain, and community engagement. • Objective 3: Promote the transition of all responsibility for sustaining and building on these gains to Bauchi State by January 2018, and to Sokoto State by January 2019, by improving capacity to promote, deliver, and monitor RI services at the State, Local Government Area (LGA), health facility (HF), and community levels. MCSP has been supporting implementation of the Bauchi State Primary Health Care Development Agency’s (SPHCDA’s) quadripartite RI strengthening memorandum of understanding (MOU) since January 20151, and of the Sokoto SPHCDA’s quadripartite RI strengthening MOU since October 2015. The program has been tasked by each state’s SPHCDA, and by the three remaining MOU signatories— USAID, the Bill & Melinda Gates Foundation (BMGF), and the Dangote Foundation—to focus on providing four areas of technical assistance: 1) Monitoring and use of data; 2) Supportive supervision; 3) Community partnership; and 4) Capacity building and training The following report covers the period from January 1 to March 31, 2017, or second quarter (Q2) of Program Year 3 (PY3). It should be noted, however, that MCSP/Nigeria RI program year follows a calendar year cycle, in line with Nigerian state government annual planning cycles. Included in this report is a summary of program achievements for the quarter, planned activities for the second quarter, and challenges, opportunities, and recommendations. 1 Skeletal operations started in January 2015 while full program implementation started in July 2015 3 | Page 1.1 Quarterly Achievement Highlights BAUCHI MOU Thematic Area 1 – Governance and Accountability All three planned state